REVIEW ON THERAPEUTIC MANAGEMENT OF PATIENTS WITH COVID-19
Gauri R. Kaphare*, Rupali S. Avhad and Harshada A. Kadam
SARS-COV-2 (severe acute respiratory syndrome corona virus) that initially came to notice in December 2019 is still spreading rapidly in whole world and it is presently a potent danger to world and also to the economy. Patients with COVID-19 are at still risk of acute respiratory distress syndrome (ARDS), respiratory failure and death. Patients aged > 60 years with comorbidities, children and health care worker are highly vulnerable to this virus patients shows various symptoms most commonly cough, fever, difficulty in breathing, fatigue, sore throat. The detailed information about the analysis of death rate by different factors like age, sex and health condition are given. Various diagnostic test for diagnosis of Covid 19 such as paper based test, RNA vaccine, molecular assay, in house develop molecular assay are discussed. General treatment can cure the disease symptomatic treatment, by using antiviral drugs, antimalarial drugs, immunomodulators, antibiotics, anti-inflammatory, vitamin D, Convalescent plasma therapy, oxygen therapy and by enhancing the immune system. Numerous clinical trials are currently under progress to test the efficacy and safety of variety of approved drugs to treat Corona virus. The review focus on latest development of diagnostic tests, vaccines, and treatment approaches for COVID-19. Here in this review all therapeutic agents against COVID-19 reported in recent times after the outbreak are being discussed.
Keywords: Diagnosis, Antivirals, Severe Acute Respiratory Syndrome, Treatment.
[Full Text Article]